Market Intelligence, Clinical Progress, and High-Purity Reagents for Oncology & Metabolic Modulation Development.
1. The TarMart Solution Ecosystem & Related Targets
Comprehensive reagent toolkit for MCT1 (SLC16A1) drug discovery. Select your modality below:
| Component / Network | Product Description | Product Link |
|---|---|---|
| Gene Delivery | MCT1 Promise-ORF / Lentivirus Full-length ORF for stable cell lines. Preserves the complex 12-transmembrane domain conformation for cell-based assays. |
View MCT1 Products |
| Antigen | MCT1 Extracellular Loop (ECL) Peptides High purity (>95%), Endotoxin <1EU/ug. Sequence Verified. Ideal for targeted antibody panning. |
View MCT1 Products |
| Benchmark Ab | Anti-MCT1 Recombinant Control Sequence-verified positive control for flow cytometry and Western Blot validation. |
View MCT1 Products |
| Validator | MCT1 siRNA Set For knockdown verification and metabolic flux baselining. |
View MCT1 Products |
| Related Target A | MCT4 (SLC16A3) Major compensatory transporter; essential for evaluating resistance bypass in the Warburg effect. |
View MCT4 Products |
| Related Target B | CD147 (Basigin) Essential chaperone interacting complex; required for MCT1 proper plasma membrane localization. |
View CD147 Products |
1.1 Critical Molecular Design & Screening Strategy
- Affinity & Kinetics: As a 12-transmembrane (TM) solute carrier, MCT1 presents severe challenges for traditional soluble screening. Soluble extracellular loops often lose native conformation. Recommend Assay: Intact cell-based Flow Cytometry and fluorescent lactate-uptake kinetic assays utilizing stably overexpressing MCT1 cell lines.
- Delivery & Biophysics: For biologics targeting the MCT1-CD147 complex, maintaining membrane stability and preventing steric hindrance during binding is critical. Recommend Assay: Whole-cell binding assays to evaluate target accessibility in the presence of the dense tumor glycocalyx.
- MoA & Internalization: The primary MoA of MCT1 inhibitors is blocking the efflux/influx of lactate and pyruvate to starve tumor cells or disrupt pH balance. Recommend Assay: Extracellular acidification rate (ECAR) monitoring and intracellular pH-sensitive dye assays on validated MCT1-expressing panels.
- Safety, Specificity & Counter Screening: The SLC16 family is highly conserved. Inhibiting MCT2 (expressed in the brain) or MCT3 can lead to severe neurological or retinal off-target toxicity. Recommend Assay: Rigorous counter-screening against MCT2, MCT3, and MCT4 stable cell lines using comparative metabolic flux to guarantee isoform selectivity.
- Cross-Species Efficacy & Toxicology (Mouse & Cyno NHP): Mouse tumor models are fundamental for testing tumor microenvironment (TME) immunomodulation via lactate depletion. Homology between Human and Mouse MCT1 requires careful evaluation for surrogate molecule selection. Recommend Assay: FACS cross-species binding validation using Cyno/Mouse ortholog lentiviral cell lines.
- Conclusion: Successful MCT1 drug discovery requires abandoning simple soluble protein assays in favor of robust, cell-based systems. Utilizing high-fidelity lentiviral delivery to express native 12-TM MCT1, combined with rigorous MCT4 counter-screening, is mandatory for validating selectivity and metabolic inhibition.
2. Why Choose TarMart? (Precision Assay Solutions)
| Critical Assay Challenge | The TarMart Advantage (Technical Spec) |
|---|---|
| Conformational Integrity of 12-TM Target | Premade Lentivirus containing full-length sequence-verified MCT1 ORF for native cell-surface expression. |
| SLC16 Family Off-Target Toxicity | MCT2/MCT3/MCT4 Lentiviral Panels for highly accurate counter-screening. |
| Cross-species cyno/mouse evaluation | Human/Mouse/Cyno ortholog ORFs strictly verified by sequencing for surrogate model validation. |
| Lack of Controls | Clinical Benchmark Antibodies included for assay standardization. |
| False Positives in Uptake Assays | Validated siRNA included for specific target knockdown and background baselining. |
3. The "Assay-Ready" Guarantee (Specs & Quality)
Accelerate your MCT1 research with reagents designed for consistency. While others offer generic membrane preparations, TarMart focuses on Structural Accuracy and Expression Quality tailored for complex multipass proteins.
- Sequence Fidelity: 100% verified match to UniProt/Clinical Patent sequences.
- Native Expression: Designed for robust membrane integration in target host cells (e.g., HEK293/CHO) to preserve critical Post-Translational Modifications and the MCT1-CD147 interactome.
- Endotoxin Control: Optimized preparation to ensure compatibility with highly sensitive cell-based metabolic assays.
4. Market Intelligence & Live R&D Tracker
? Live MCT1 R&D Tracker
Market data changes daily. Access the latest global pipeline status directly:
b) Global Clinical Landscape & Future Outlook
The race for MCT1 therapeutics is heavily focused on small molecule inhibitors (e.g., AZD3965), primarily targeting solid tumors and hematological malignancies by disrupting the Warburg effect. As first-generation therapies reach the clinic, the next wave of R&D is targeting dual MCT1/MCT4 inhibition to overcome metabolic plasticity and exploring MCT1 as a modulator for enhancing the efficacy of immune checkpoint inhibitors in the acidic tumor microenvironment.
c) Competitive Modality & Indication Snapshot
| Modality | Representative Players | Key Indications | Critical Assay Need (Why TarMart?) |
|---|---|---|---|
| Small Molecule | AstraZeneca (AZD3965), various biotechs | Advanced Solid Tumors, DLBCL | Cell-based IC50 / Lactate Flux (Need Lentivirus for Stable Cell Lines) |
| Monoclonal Ab | Emerging Preclinical | Immunosuppression / TME Modulation | Epitope Conformation (Need high-fidelity native expression) |
| Dual Inhibitors | Preclinical consortia | Refractory Cancers (MCT4 comp.) | Selectivity Assay (Need both MCT1 and MCT4 cell lines) |
5. SEO Meta Data
- Title: MCT1 Market Landscape & Assay Reagents | TarMart
- Description: Buy high-fidelity MCT1 lentivirus, sequence-verified controls, and siRNA. Analyze clinical trends and metabolic modulation with our live tracker.
- Keywords: MCT1 recombinant, SLC16A1 lentivirus, AZD3965 biosimilar, MCT1 market forecast, Warburg effect drug target, CD147 complex.
